Imidazolyl-PEI modified nanoparticles for enhanced gene delivery.

The derivatives of polyethylenimine (PEI 25 and 750kDa) were synthesized by partially substituting their amino groups with imidazolyl moieties. The series of imidazolyl-PEIs thus obtained were cross-linked with polyethylene glycol (PEG) to get imidazolyl-PEI-PEG nanoparticles (IPP). The component of hydrophobicity was introduced by grafting the lauryl groups in the maximal substituted IPP nanoparticles (IPPL). The nanoparticles were characterized with respect to DNA interaction, hydrodynamic diameter, zeta potential, in vitro cytotoxicity and transfection efficiency on model cell lines. The IPP and IPPL nanoparticles formed a loose complex with DNA compared to the corresponding native PEI, leading to more efficient unpackaging of DNA. The DNA loading capacity of IPP and IPPL nanoparticles was also lower compared to PEI. The imidazolyl substitution improved the gene delivery efficiency of PEI (750kDa) by nine- to ten-fold and PEI (25kDa) by three- to four-fold. At maximum transfection efficiency, the zeta potential of nanoparticles was positive after forming a complex with DNA. The maximum level of reporter gene expression was mediated by IPPL nanoparticles in both the series. The cytotoxicity, another pertinent problem with cationic polymers, was also negligible in case of IPP and IPPL nanoparticles.

[1]  C. Pichon,et al.  Histidine-rich peptides and polymers for nucleic acids delivery. , 2001, Advanced drug delivery reviews.

[2]  Stefaan C. De Smedt,et al.  Cationic Polymer Based Gene Delivery Systems , 2000, Pharmaceutical Research.

[3]  Kabanov,et al.  Taking polycation gene delivery systems from in vitro to in vivo. , 1999, Pharmaceutical science & technology today.

[4]  S. W. Kim,et al.  pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. , 2000, Bioconjugate chemistry.

[5]  F. Alexis,et al.  Low molecular weight polyethylenimines linked by β‐cyclodextrin for gene transfer into the nervous system , 2006, The journal of gene medicine.

[6]  D. Putnam,et al.  Structure-function relationships of gene delivery vectors in a limited polycation library. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Jung Wan Hong,et al.  PEGylated polyethylenimine for in vivo local gene delivery based on lipiodolized emulsion system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[8]  D. W. Pack,et al.  Partial Acetylation of Polyethylenimine Enhances In Vitro Gene Delivery , 2004, Pharmaceutical Research.

[9]  Jong-sang Park,et al.  Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Y. Tan,et al.  Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[11]  Olivier Danos,et al.  Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Fischer,et al.  Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[13]  W. Walther,et al.  Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting , 1996, Journal of Molecular Medicine.

[14]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  In-Kyu Park,et al.  Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): in vitro and in vivo studies. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Shubiao Zhang,et al.  Cationic compounds used in lipoplexes and polyplexes for gene delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[17]  J. Rosenecker,et al.  Uronic acids functionalized polyethyleneimine (PEI)-polyethyleneglycol (PEG)-graft-copolymers as novel synthetic gene carriers. , 2006, Biomaterials.

[18]  Mansoor Amiji,et al.  Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery , 2002, Pharmaceutical Research.

[19]  K Mechtler,et al.  The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells , 1998, Gene Therapy.

[20]  P. Dubruel,et al.  Buffering properties of cationic polymethacrylates are not the only key to successful gene delivery. , 2004, Biomacromolecules.

[21]  Navarro,et al.  Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors. , 1998, Advanced drug delivery reviews.

[22]  Christine Vauthier,et al.  Pegylated Nanoparticles from a Novel Methoxypolyethylene Glycol Cyanoacrylate-Hexadecyl Cyanoacrylate Amphiphilic Copolymer , 1998, Pharmaceutical Research.

[23]  K. Gupta,et al.  Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Y. Li,et al.  Characterization of commercially available and synthesized polyethylenimines for gene delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[25]  M. Monsigny,et al.  Efficient gene transfer by histidylated polylysine/pDNA complexes. , 1999, Bioconjugate chemistry.

[26]  M Laird Forrest,et al.  Cyclodextrin-polyethylenimine conjugates for targeted in vitro gene delivery. , 2005, Biotechnology and bioengineering.

[27]  G. Merlo,et al.  Polyethylenimine-based intravenous delivery of transgenes to mouse lung , 1998, Gene Therapy.

[28]  M. Buchberger,et al.  Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery , 1997, Gene Therapy.

[29]  J. Nah,et al.  Glucosylated polyethylenimine as a tumor-targeting gene carrier , 2005, Archives of pharmacal research.

[30]  M. O'Neill,et al.  Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine , 2001, Gene Therapy.

[31]  J. Kopeček,et al.  PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice. , 2005, Bioconjugate chemistry.

[32]  J. Coll,et al.  Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes , 2002, The journal of gene medicine.

[33]  W. Tseng,et al.  The role of dextran conjugation in transfection mediated by dextran‐grafted polyethylenimine , 2004, The journal of gene medicine.

[34]  P. Midoux,et al.  Histidylated polylysine as DNA vector: elevation of the imidazole protonation and reduced cellular uptake without change in the polyfection efficiency of serum stabilized negative polyplexes. , 2001, Bioconjugate chemistry.

[35]  R. Mulligan,et al.  The basic science of gene therapy. , 1993, Science.

[36]  A. Klibanov,et al.  Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Müller,et al.  Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[38]  T. Bieber,et al.  Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[39]  E. Wagner,et al.  Design and gene delivery activity of modified polyethylenimines. , 2001, Advanced drug delivery reviews.

[40]  D. Putnam,et al.  Design of imidazole-containing endosomolytic biopolymers for gene delivery. , 2000, Biotechnology and bioengineering.

[41]  R. Wattiaux,et al.  Endosomes, lysosomes: their implication in gene transfer. , 2000, Advanced drug delivery reviews.

[42]  M. Monsigny,et al.  Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides. , 2000, Nucleic acids research.

[43]  M. Monsigny,et al.  Membrane permeabilization and efficient gene transfer by a peptide containing several histidines. , 1998, Bioconjugate chemistry.